NXSCF (Next Science) Beneish M-Score : -4.06 (As of Mar. 27, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.06 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Next Science's Beneish M-Score or its related term are showing as below:

NXSCF' s Beneish M-Score Range Over the Past 10 Years
Min: -4.06 Med: -1.97 Max: -1.65
Current: -4.06

During the past 7 years, the highest Beneish M-Score of Next Science was -1.65. The lowest was -4.06. And the median was -1.97.

Next Science Beneish M-Score Historical Data

The historical data trend for Next Science's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Beneish M-Score Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beneish M-Score

Get a 7-Day Free Trial

-1.65

-1.70

-2.42

-1.97

-4.06

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Beneish M-Score	Get a 7-Day Free Trial							-2.42	-	-1.97	-	-4.06

Competitive Comparison of Next Science's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Next Science's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Next Science's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Next Science's Beneish M-Score falls into.

Save Embed

;

Save Embed

;

Next Science Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Next Science for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.9033

0.528 * 0.9056

0.404 * 1.6758

0.892 * 1.0287

0.115 * 0.7799

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.8606

4.679 * -0.287063

0.327 * 2.3575

-4.11

This Year (Dec24) TTM:

Last Year (Dec23) TTM:

Total Receivables was $3.34 Mil.
Revenue was $22.82 Mil.
Gross Profit was $18.44 Mil.
Total Current Assets was $6.05 Mil.
Total Assets was $9.21 Mil.
Property, Plant and Equipment(Net PPE) was $1.07 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.27 Mil.
Selling, General, & Admin. Expense(SGA) was $22.82 Mil.
Total Current Liabilities was $3.22 Mil.
Long-Term Debt & Capital Lease Obligation was $2.27 Mil.
Net Income was $-10.59 Mil.
Gross Profit was $0.02 Mil.
Cash Flow from Operations was $-7.96 Mil.

Total Receivables was $3.59 Mil.
Revenue was $22.18 Mil.
Gross Profit was $16.24 Mil.
Total Current Assets was $13.96 Mil.
Total Assets was $17.90 Mil.
Property, Plant and Equipment(Net PPE) was $1.52 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.11 Mil.
Selling, General, & Admin. Expense(SGA) was $25.78 Mil.
Total Current Liabilities was $3.84 Mil.
Long-Term Debt & Capital Lease Obligation was $0.69 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(3.335 / 22.816)	/	(3.589 / 22.179)
	=	0.146169	/	0.16182
	=	0.9033

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(16.235 / 22.179)	/	(18.443 / 22.816)
	=	0.731999	/	0.808336
	=	0.9056

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (6.051 + 1.072) / 9.214)	/	(1 - (13.96 + 1.516) / 17.9)
	=	0.226937	/	0.135419
	=	1.6758

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	22.816	/	22.179
	=	1.0287

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(1.113 / (1.113 + 1.516))	/	(1.273 / (1.273 + 1.072))
	=	0.423355	/	0.542857
	=	0.7799

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(22.82 / 22.816)	/	(25.776 / 22.179)
	=	1.000175	/	1.16218
	=	0.8606

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((2.271 + 3.219) / 9.214)	/	((0.687 + 3.837) / 17.9)
	=	0.595832	/	0.252737
	=	2.3575

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-10.586 - 0.022	-	-7.963)	/	9.214
	=	-0.287063

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Next Science has a M-score of -4.11 suggests that the company is unlikely to be a manipulator.

Next Science Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Next Science's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (OTCPK:NXSCF) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

NXS:Australia

Address

264-278 George Street, Level 14, Australia Square, HWL Ebsworth, Sydney, NSW, AUS, 2000

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.